PL3345899T3 - Pochodne benzofurano-2-sulfonoamidu jako modulatory receptorów chemokin - Google Patents

Pochodne benzofurano-2-sulfonoamidu jako modulatory receptorów chemokin

Info

Publication number
PL3345899T3
PL3345899T3 PL18156011T PL18156011T PL3345899T3 PL 3345899 T3 PL3345899 T3 PL 3345899T3 PL 18156011 T PL18156011 T PL 18156011T PL 18156011 T PL18156011 T PL 18156011T PL 3345899 T3 PL3345899 T3 PL 3345899T3
Authority
PL
Poland
Prior art keywords
benzofuran
chemokine receptor
receptor modulators
sulfonamide derivatives
sulfonamide
Prior art date
Application number
PL18156011T
Other languages
English (en)
Inventor
Haiqing Yuan
Richard L. Beard
Xiaoxia Liu
John E. Donello
Veena Viswanath
Michael E. Garst
Original Assignee
Allergan, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan, Inc. filed Critical Allergan, Inc.
Publication of PL3345899T3 publication Critical patent/PL3345899T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL18156011T 2012-03-01 2013-03-01 Pochodne benzofurano-2-sulfonoamidu jako modulatory receptorów chemokin PL3345899T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261605300P 2012-03-01 2012-03-01
EP13711995.4A EP2820010B1 (en) 2012-03-01 2013-03-01 Benzofuran-2-sulfonamide derivatives as chemokine receptor modulators
PCT/US2013/028607 WO2013130962A1 (en) 2012-03-01 2013-03-01 Benzofuran- 2 - sulfonamide derivatives as chemokine receptor modulators
EP18156011.1A EP3345899B1 (en) 2012-03-01 2013-03-01 Benzofuran-2-sulfonamide derivatives as chemokine receptor modulators

Publications (1)

Publication Number Publication Date
PL3345899T3 true PL3345899T3 (pl) 2020-07-27

Family

ID=47902352

Family Applications (2)

Application Number Title Priority Date Filing Date
PL13711995T PL2820010T3 (pl) 2012-03-01 2013-03-01 Pochodne benzofurano-2-sulfonamidu jako modulatory receptora chemokinowego
PL18156011T PL3345899T3 (pl) 2012-03-01 2013-03-01 Pochodne benzofurano-2-sulfonoamidu jako modulatory receptorów chemokin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL13711995T PL2820010T3 (pl) 2012-03-01 2013-03-01 Pochodne benzofurano-2-sulfonamidu jako modulatory receptora chemokinowego

Country Status (12)

Country Link
US (4) US8815915B2 (pl)
EP (2) EP3345899B1 (pl)
AU (2) AU2013225815B2 (pl)
CA (1) CA2866078C (pl)
CY (1) CY1120528T1 (pl)
DK (2) DK3345899T3 (pl)
ES (2) ES2791534T3 (pl)
HU (2) HUE038700T2 (pl)
PL (2) PL2820010T3 (pl)
PT (2) PT2820010T (pl)
SI (1) SI2820010T1 (pl)
WO (2) WO2013130958A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3345899T3 (da) * 2012-03-01 2020-05-11 Allergan Inc Benzofuran-2-sulfonamidderivater som kemokinreceptormodulatorer
ES2708563T3 (es) * 2013-03-12 2019-04-10 Allergan Inc Derivados de sulfonamida como moduladores de receptores de quimiocinas
US20150152080A1 (en) * 2013-12-02 2015-06-04 Allergan, Inc. Benzothiophene sulfonamides derivatives as chemokine receptor modulators

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2399903A1 (en) 2002-05-24 2011-12-28 Millennium Pharmaceuticals, Inc. Ccr9 inhibitors and methods of use thereof
US20070021466A1 (en) * 2002-11-18 2007-01-25 Solomon Ungashe CCR2 inhibitors and methods of use thereof
US7420055B2 (en) 2002-11-18 2008-09-02 Chemocentryx, Inc. Aryl sulfonamides
EP1643960A2 (en) 2003-07-02 2006-04-12 Merck & Co., Inc. Arylsulfonamide derivatives
EA200600203A1 (ru) * 2003-08-08 2006-08-25 Янссен Фармацевтика, Н. В. Производные 2-(хиноксалин-5-илсульфониламино)бензамида в качестве модуляторов сск2
US7622583B2 (en) * 2005-01-14 2009-11-24 Chemocentryx, Inc. Heteroaryl sulfonamides and CCR2
US7931909B2 (en) 2005-05-10 2011-04-26 Allergan, Inc. Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
GB0524786D0 (en) 2005-12-05 2006-01-11 Glaxo Group Ltd Compounds
EA015710B1 (ru) 2006-07-14 2011-10-31 Хемоцентрикс, Инк. Триазолил фенилбензолсульфонамиды
WO2008008374A2 (en) 2006-07-14 2008-01-17 Chemocentryx, Inc. Ccr2 inhibitors and methods of use thereof
US8519135B2 (en) 2006-07-14 2013-08-27 Chemocentryx, Inc. Heteroaryl sulfonamides and CCR2/CCR9
ES2383568T3 (es) 2007-07-12 2012-06-22 Chemocentryx, Inc. Heteroaril piridil y fenil bencenosulfonamidas condensadas como moduladores de CCR2 para el tratamiento de la inflamación
TWI440638B (zh) * 2007-10-30 2014-06-11 Otsuka Pharma Co Ltd 雜環化合物及其藥學組成物
CN108383828A (zh) * 2010-12-16 2018-08-10 阿勒根公司 作为趋化因子受体调节剂的新的1,2-双-磺酰胺衍生物
JP5917555B2 (ja) * 2010-12-16 2016-05-18 アラーガン、インコーポレイテッドAllergan,Incorporated ケモカイン受容体調節因子としてのリン酸誘導体
US8524745B2 (en) * 2011-12-12 2013-09-03 Allergan, Inc. Benzisothiazol-3(1H)-one-5-sulfonyl derivatives as chemokine receptor modulators
DK3345899T3 (da) * 2012-03-01 2020-05-11 Allergan Inc Benzofuran-2-sulfonamidderivater som kemokinreceptormodulatorer
ES2708563T3 (es) * 2013-03-12 2019-04-10 Allergan Inc Derivados de sulfonamida como moduladores de receptores de quimiocinas

Also Published As

Publication number Publication date
PL2820010T3 (pl) 2018-11-30
AU2013225815B2 (en) 2017-10-12
CY1120528T1 (el) 2019-07-10
DK2820010T3 (en) 2018-08-06
US9416120B2 (en) 2016-08-16
AU2018200226B2 (en) 2019-09-19
DK3345899T3 (da) 2020-05-11
CA2866078A1 (en) 2013-09-06
ES2683046T3 (es) 2018-09-24
ES2791534T3 (es) 2020-11-04
SI2820010T1 (sl) 2018-11-30
US20130231339A1 (en) 2013-09-05
EP2820010A1 (en) 2015-01-07
WO2013130958A1 (en) 2013-09-06
WO2013130962A1 (en) 2013-09-06
EP3345899A1 (en) 2018-07-11
US20150218119A1 (en) 2015-08-06
AU2018200226A1 (en) 2018-01-25
HUE038700T2 (hu) 2018-11-28
US20130231338A1 (en) 2013-09-05
HUE049728T2 (hu) 2020-10-28
AU2013225815A1 (en) 2014-09-25
EP3345899B1 (en) 2020-02-19
US9550746B2 (en) 2017-01-24
EP2820010B1 (en) 2018-05-09
US8927544B2 (en) 2015-01-06
US20140329813A1 (en) 2014-11-06
PT3345899T (pt) 2020-05-20
PT2820010T (pt) 2018-10-01
US8815915B2 (en) 2014-08-26
CA2866078C (en) 2018-01-02

Similar Documents

Publication Publication Date Title
GB201213700D0 (en) Receptor antagnists II
IL237212A0 (en) Amide derivatives of benzoimidazole carboxylic acid as apj receptor modulators
EP2838881A4 (en) ISO-INDOLONE DERIVATIVES
IL236024A0 (en) History of benzaimidazole-proline
PL2844659T3 (pl) Pochodne pirrolotriazynonowe
ZA201406390B (en) Liver x receptor modulators
AP2015008347A0 (en) Oxazolidin-2-one-pyrimidine derivatives
ZA201406326B (en) Liver x receptor modulators
ZA201500096B (en) Indolecarbonitriles as selective androgen receptor modulators
IL235557A0 (en) Modulators of 17 gpr receptors
IL239076A0 (en) Novel and selective androgen receptor modulators
GB201217285D0 (en) Indole derivatives
GB201223053D0 (en) Receptor
SI2820010T1 (sl) Derivati benzofuran-2-sulfonamida kot modulatorji kemokinskih receptorjev
AU2012904244A0 (en) Neurotrophin-tyrosine kinase receptor signaling
HUP1200360A2 (en) Resolution by using n-acyl-phenylglycine derivatives